A randomized, controlled trial of high dose, inhaled budesonide versus oral prednisone in patients discharged from the emergency department following an acute asthma exacerbation

Canadian Respiratory Journal

Volumn 7, Issue 1, 2000, Pages 61-67

  Mark Fitzgerald, J ^a  

^a VANCOUVER HOSPITAL AND HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Acute asthma; Budesonide; Emergency department; Inhaled glucocorticosteroids; Turbuhaler

Indexed keywords

BUDESONIDE; GLUCOCORTICOID; PREDNISONE;

ADULT; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DYSPEPSIA; EMERGENCY WARD; FEMALE; FORCED EXPIRATORY VOLUME; HEADACHE; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RECURRENCE RISK; SIDE EFFECT; TASTE DISORDER;

EID: 0034054024     PISSN: 11982241     EISSN: None     Source Type: Journal    
DOI: 10.1155/2000/587957     Document Type: Article

References (2)

1. FitzGerald JM, Grunfeld A. Status asthmaticus. In: Lichetenstein LM, Fauci AS, eds. Current Therapy in Allergy, Immunology and Rheumatology. St Louis: Mosby, 1996:63-7.
2. FitzGerald JM, Grunfeld A, Pare PD, et al. The clinical efficacy of combination nebulized anticholinergic and adrenergic bronchodilators vs nebulized adrenergic bronchodilator alone in acute asthma. Canadian Combivent Study Group. Chest 1997;111:311-5.